Effects of sodium butyrate on growth, differentiation, and apoptosis in head and neck squamous carcinoma cell lines

Head and Neck

Volumn 22, Issue 3, 2000, Pages 247-256

  Gillenwater, Ann ^a   Zou, Chang Ping ^b   Zhong, Meiling ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Differentiating agents; Growth inhibition; Histone deacetylase inhibitor

Indexed keywords

BUTYRIC ACID; ENZYME INHIBITOR; HISTONE DEACETYLASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COLORIMETRY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BUTYRATES; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL DIVISION; CHI-SQUARE DISTRIBUTION; FLOW CYTOMETRY; G1 PHASE; GENES, BCL-2; HEAD AND NECK NEOPLASMS; HUMANS; REFERENCE VALUES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034003713     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(200005)22:3<247::AID-HED7>3.0.CO;2-O     Document Type: Article

References (53)

1. Slaughter DP, Southwick HW, Smejkel W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6: 963-968.
2. Strong MS, Incze J, Vaughn CW. Field cancerization in the aerodigestive tract - Its etiology, manifestation, and significance. J Otolaryngol 1984;13:1-6.
3. Hong W, Endicott J, Itri LM, et al. 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J. Med 1986; 315:1501-1505.
4. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323: 795-801.
5. Moon RC, Mehta RG. Retinoid inhibition of experimental carcinogenesis. In: Dawson MI, Okamura WH, editors. Chemistry and biology of synthetic retinoids. Boca Raton, FL: CRC Press; 1990. p 501-518.
6. Sacks PG, Oke V, Amos B, Vasey T, Lotan R. Modulation of growth, differentiation, and glycoprotein synthesis by beta-all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int J Cancer 1989;45:926-933.
7. Prasad KN, Sinha PK. Effect of sodium butyrate on mammalian cells in culture: a review. In Vitro 1976;12: 125-132.
8. Fagot D, Buquet-Fagot C, Lallemand F, Mester J. Anti-proliferative effects of sodium butyrate in Adriamycin-sensitive and -resistant human cancer cell lines. Anticancer Drugs 1994;5:548-556.
9. Barnard JA, Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 1993;4:495-501.
10. Kip1. Surgery 1998;124:161-170.
11. Cummings JH, Pomare EW, Branch WJ, Naylor CPE, MacFarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28: 1221-1227.
12. Novogrodsky A, Dvir A, Ravid A. Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer 1983;51:9-14.
13. Miller AA, Kurschel E, Osieka R, Schmidt CG. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 1987;23:1283-1287.
14. Perrine SP, Ginder GD, Faller DV. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med 1993;328:81-86.
15. Newmark HL, Lupton JR, Young CW. Butyrate as a differentiating agent: Pharmacokinetics, analogues and current status. Cancer Lett 1994;78:1-5.
16. Floyd EE, Jetten AM. Regulation of type I (epidermal) transglutaminase mRNA levels during squamous differentiation: downregulation by retinoids. Mol Cell Biol 1989;9:4846-4851.
17. Eckert RL, Green H. Structure and evolution of the human involucrin gene. Cell 1986;46:583-589.
18. Steinert PM, Parry DA, Idler WW, Johnson LD, Steven AC, Roop DR. Amino acid sequences of mouse and human epidermal type II keratins of Mr 67,000 provide a systematic basis for the structural and functional diversity of the end domains of keratin intermediate filament subunits. J Biol Chem 1985;260:7142-7149.
19. Dugaiczyk A, Haron JA, Stone EM, Dennison OE, Rothblum KN, Schwartz RJ. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry 1983;22;1605-1613.
20. Tuck SP, Crawford L. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion. Oncogene Res 1989;4:81-96.
21. Chomczynski P, Sacchi N. Single step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
22. Zou CP, Clifford JL, Xu X-C, et al. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res 1994;54:5479-5487.
23. Gavrieli Y, Sherman Y, Ben-Saason SA. Identification of programmed cell death: In situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;199: 493-501.
24. D'Anna JA, Tobey RA, Gurley LR. Concentration-dependent effects of sodium butyrate in Chinese hamster cells: Cell-cycle progression, inner-histone acetylation, histone H1 dephosphorylation, and induction of an H1-like protein. Biochemistry 1980;19:2656-2671.
25. 1 phase. J Cell Biochem 1983;21:239-247.
26. Mandel M, Kumar R. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ 1996;7:311-318.
27. Mandel M, Wu X, Kumar R. Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells. Carcinogenesis 1997;18: 229-232.
28. Kuo M-H, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 1998;20: 615-626.
29. Nan X, Ng H-H, Johnson CA, et al. Transcriptional repression by methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998;393:386-389.
30. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet 1998;19(2):187-191.
31. Candido EPM, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 1978; 14:105-113.
32. Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell 1978;14:115-121.
33. Vidali G, Boffa LC, Bradbury EM, Allfrey VG. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA 1978;75:2239-2243.
34. Lee DY, Hayes JJ, Pruss D, Wolffe AP. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 1993;72:73-84.
35. Arts J, Lansink M, Grimbergen J, Toet KH, Kooistra T. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J 1995;310:171-176.
36. Lotan R. Squamous cell differentiation markers in normal, premalignant, and malignant epithelium: effects of retinoids. J Cell Biochem (Suppl) 1993;17:167-174.
37. Brown LJ, Geesin JC, Rothnagel JA, Roop DR, Gordon JS. Retinoic acid suppression of loricrin expression in reconstituted human skin cultured at the liquid-air interface. J Invest Dermatol 1994;102:886-890.
38. Staiano-Coico L, McMahon CK, Pagan-Gharry I, LaBruna A, Piraino V, Higgins PJ. Sodium-N-butyrate induces cytoskeletal rearrangements and formation of cornified envelopes in cultured adult human keratinocytes. Cellular Tissue Kinetics 1989;22:361-375.
39. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984;44:3961-3969.
40. Schwartz B, Avivi-Green C, Polak-Charcon S. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem 1998;188:21-30.
41. Leder A, Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemia cells. Cell 1975;5:319-322.
42. Schmidt R, Cathelineau C, Cavey MT, et al. Sodium butyrate selectively antagonizes the inhibitory effect of retinoids on cornified envelope formation in cultured human keratinocytes. J Cell Physiol 1989;140:281-287.
43. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonie tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1988;55:498-505.
44. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonie carcinoma cell lines. Cancer Res 1994;54:3288-3294.
45. Calabresse C, Venturini L, Ronco G, Villa P, Chomienne C, Belpomme D. Butyric acid and its monosaecharide ester induce apoptosis in the HL-60 cell line. Biochem Biophys Res Commun 1993;195:31-38.
46. Filippovich I, Sorokina N, Khanna KK, Lavin MF. Butyrate induced apoptosis in lymphoid cell preceded transient over-expression of HSP70 mRNA. Biochem Biophys Res Commun 1994;198:257-265.
47. Conway RM, Madigan MC, Penfold PL, Bilson FA. Induction of apoptosis by sodium butyrate in the human Y-79 retinoblastoma cell line. Oncol Res 1995;7:289-297.
48. McBain JA, Eastman A, Nobel CS, Mueller GC. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 1997;53:1357-1368.
49. Medina V, Edmonds B, Young GP, et al. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 1997; 57:3697-3707.
50. Alexandrov I, Romanova L, Mushinshki F, Nordan R. Sodium butyrate suppresses apoptosis in human Burkitt lymphomas and murine plasmacytomas bearing c-myc translocations. FEBS Lett 1998;434:209-214.
51. Czerniak B, Herz F, Westo RP, Koss LG. Modification of H-ras oncogene p21 expression and cell cycle progression in the human colon cancer cell line HT-29. Cancer Res 1987;47:2826-2830.
52. Archer S, Meng S, Wu J, et al. Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery 1998;124:248-253.
53. Buquet-Fagot C, Lallemand F, Charollais R-H, Mester J. Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism. J Cell Phys 1996;166: 631-636.